Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marta Sisteré-Oró"'
Autor:
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, Mireya L. Borrajo, Gustavo Lou, Lorenzo Franceschini, Ignasi Esteban, Pedro J. Sánchez-Cordón, Carmen Zamora, Carlos Óscar S. Sorzano, Luis Jordá, Laia Codó, Josep L. Gelpí, Marta Sisteré-Oró, Andreas Meyerhans, Kris Thielemans, Francisco Martínez-Jiménez, Núria López-Bigas, Felipe García, María J. Alonso, Montserrat Plana, Mariano Esteban, Carmen Elena Gómez
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-15 (2024)
Abstract Vaccines based on mRNA technology have revolutionized the field. In fact, lipid nanoparticles (LNP) formulated with mRNA are the preferential vaccine platform used in the fight against SARS-CoV-2 infection, with wider application against oth
Externí odkaz:
https://doaj.org/article/9161a691dc534dadb8067291bb76b860
Autor:
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, Mireya L. Borrajo, Gustavo Lou, Lorenzo Franceschini, Ignasi Esteban, Pedro J. Sánchez-Cordón, Carmen Zamora, Carlos Óscar S. Sorzano, Luis Jordá, Laia Codó, Josep L. Gelpí, Marta Sisteré-Oró, Andreas Meyerhans, Kris Thielemans, Francisco Martínez-Jiménez, Núria López-Bigas, Felipe García, María J. Alonso, Montserrat Plana, Mariano Esteban, Carmen Elena Gómez
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/65c430fb91f54fc0aada194799ba02ca
Autor:
Ignasi Esteban, Carmen Pastor-Quiñones, Lorena Usero, Elena Aurrecoechea, Lorenzo Franceschini, Arthur Esprit, Josep Lluís Gelpí, Francisco Martínez-Jiménez, Núria López-Bigas, Karine Breckpot, Kris Thielemans, Lorna Leal, Carmen Elena Gómez, Marta Sisteré-Oró, Andreas Meyerhans, Mariano Esteban, María José Alonso, Felipe García, Montserrat Plana
Publikováno v:
Vaccines, Vol 12, Iss 1, p 15 (2023)
The COVID-19 pandemic has brought significant changes and advances in the field of vaccination, including the implementation and widespread use of encapsidated mRNA vaccines in general healthcare practice. Here, we present two new mRNAs expressing an
Externí odkaz:
https://doaj.org/article/5049aac8017e41528739adfc92cee953
Autor:
Antoni Prenafeta, Gregori Bech-Sàbat, Alexandra Moros, Antonio Barreiro, Alex Fernández, Manuel Cañete, Mercè Roca, Luis González-González, Carme Garriga, Joachim Confais, Marion Toussenot, Hugues Contamin, Andrés Pizzorno, Manuel Rosa-Calatrava, Edwards Pradenas, Silvia Marfil, Julià Blanco, Paula Cebollada Rica, Marta Sisteré-Oró, Andreas Meyerhans, Cristina Lorca, Joaquim Segalés, Teresa Prat, Ricard March, Laura Ferrer
Publikováno v:
iScience, Vol 26, Iss 7, Pp 107224- (2023)
Summary: SARS-CoV-2 emerged in December 2019 and quickly spread worldwide, continuously striking with an unpredictable evolution. Despite the success in vaccine production and mass vaccination programs, the situation is not still completely controlle
Externí odkaz:
https://doaj.org/article/9369697d1b964e229177289631f80d99
Autor:
Laura Marcos-Villar, Beatriz Perdiguero, María López-Bravo, Carmen Zamora, Laura Sin, Enrique Álvarez, Carlos Óscar S. Sorzano, Pedro J. Sánchez-Cordón, José M. Casasnovas, David Astorgano, Juan García-Arriaza, Shubaash Anthiya, Mireya L. Borrajo, Gustavo Lou, Belén Cuesta, Lorenzo Franceschini, Josep L. Gelpí, Kris Thielemans, Marta Sisteré-Oró, Andreas Meyerhans, Felipe García, Ignasi Esteban, Núria López-Bigas, Montserrat Plana, María J. Alonso, Mariano Esteban, Carmen Elena Gómez
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
Despite the high efficiency of current SARS-CoV-2 mRNA vaccines in reducing COVID-19 morbidity and mortality, waning immunity and the emergence of resistant variants underscore the need for novel vaccination strategies. This study explores a heterolo
Externí odkaz:
https://doaj.org/article/249ddc44798e493a9e82b35d7493dba3
Autor:
Antonio Barreiro, Antoni Prenafeta, Gregori Bech-Sabat, Mercè Roca, Eva Perozo Mur, Ricard March, Luis González-González, Laia Madrenas, Júlia Corominas, Alex Fernández, Alexandra Moros, Manuel Cañete, Mercè Molas, Thais Pentinat-Pelegrin, Clara Panosa, Alberto Moreno, Ester Puigvert Molas, Eva Pol Vilarrassa, Jordi Palmada, Carme Garriga, Teresa Prat Cabañas, Javier Iglesias-Fernández, Júlia Vergara-Alert, Cristina Lorca-Oró, Núria Roca, Leira Fernández-Bastit, Jordi Rodon, Mònica Pérez, Joaquim Segalés, Edwards Pradenas, Silvia Marfil, Benjamin Trinité, Raquel Ortiz, Bonaventura Clotet, Julià Blanco, Jorge Díaz Pedroza, Rosa Ampudia Carrasco, Yaiza Rosales Salgado, Jordina Loubat-Casanovas, Sara Capdevila Larripa, Julia Garcia Prado, Jordi Barretina, Marta Sisteré-Oró, Paula Cebollada Rica, Andreas Meyerhans, Laura Ferrer
Publikováno v:
iScience, Vol 26, Iss 3, Pp 106126- (2023)
Summary: Current COVID-19 vaccines have been associated with a decline in infection rates, prevention of severe disease, and a decrease in mortality rates. However, SARS-CoV-2 variants are continuously evolving, and development of new accessible COVI
Externí odkaz:
https://doaj.org/article/d0726f4810564a71891b55321b0794c7
Autor:
Marta Sisteré-Oró, Naina Andrade, Diana D.J. Wortmann, Juan Du, Natalia Garcia-Giralt, María González-Cao, Robert Güerri-Fernández, Andreas Meyerhans
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Individuals infected with the human immunodeficiency virus type 1 (HIV-1) belong to the group of people most vulnerable to SARS-CoV-2 infections and the associated disease COVID-19. Here we describe SARS-CoV-2-specific antibody and cellular immune re
Externí odkaz:
https://doaj.org/article/e60ed32317554dfb80efcb1acf9208ff
Autor:
Marta Sisteré-Oró, Diana D. J. Wortmann, Naína Andrade, Andres Aguilar, Clara Mayo de las Casas, Florencia Garcia Casabal, Susana Torres, Eduardo Bona Salinas, Laura Raventos Soler, Andrea Arcas, Carlos Esparre, Beatriz Garcia, Joselyn Valarezo, Rafael Rosell, Roberto Güerri-Fernandez, Maria Gonzalez-Cao, Andreas Meyerhans
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Cancer patients (CPs) have been identified as particularly vulnerable to SARS-CoV-2 infection, and therefore are a priority group for receiving COVID-19 vaccination. From the patients with advanced solid tumors, about 20% respond very efficiently to
Externí odkaz:
https://doaj.org/article/39f4056541bb4a58a41c69551c380734
Autor:
Marta Sisteré-Oró, Gabriel K. Pedersen, Lorena Córdoba, Sergi López-Serrano, Dennis Christensen, Ayub Darji
Publikováno v:
Veterinary Research, Vol 51, Iss 1, Pp 1-11 (2020)
Abstract Conserved epitopes are targets commonly researched to be part of universal vaccine candidates against influenza viruses (IV). These conserved epitopes need to be cross-protecting against distinct IV subtypes and to have a strong immunogenic
Externí odkaz:
https://doaj.org/article/c6aca88bd9ac4b448b4121d03b1b5932
Autor:
Álvaro López-Valiñas, Marta Sisteré-Oró, Sergi López-Serrano, Laura Baioni, Ayub Darji, Chiara Chiapponi, Joaquim Segalés, Llilianne Ganges, José I. Núñez
Publikováno v:
Viruses, Vol 13, Iss 10, p 2087 (2021)
Influenza viruses represent a continuous threat to both animal and human health. The 2009 H1N1 A influenza pandemic highlighted the importance of a swine host in the adaptation of influenza viruses to humans. Nowadays, one of the most extended strate
Externí odkaz:
https://doaj.org/article/959db5be8087422b837204f0082be1e2